Announce Date | 06/06/2025 |
EPS Normalized Actual | $0.86 (Miss by $-0.01) |
EPS GAAP Actual | $0.86 (Miss by $-0.01) |
Revenue Actual | $2.1117B |
Revenue Surprise | Beat by $2111.7M |
Announce Date | 07/31/2025 (Pre-Market) |
EPS Normalized Estimate | $0.97976 |
EPS GAAP Estimate | $0.97976 |
Revenue Estimate | $2.105186714B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Oct 2026 | 3.71769 | 12.99 | 3.63241 | 3.81037 | 1 |
Oct 2025 | 3.31846 | 14.55 | 3 | 3.62 | 5 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Apr 2025) | 0.67 | 0.67 | 2.1117B | 4.43% | 2111.7M |
FQ1 2025 (Jan 2025) | 0.7 | 0.7 | 2.1149B | 2.14% | 2114.9M |
FQ4 2024 (Oct 2024) | -0.19 | -0.19 | 2.1773B | 3.88% | 2177.3M |
FQ3 2024 (Jul 2024) | 0.0745 | 0.0745 | 2.0942B | 3.15% | 2094.2M |
FQ2 2024 (Apr 2024) | 0.69 | 0.69 | 2.0182B | 1.69% | 2018.2M |
FQ1 2024 (Jan 2024) | 0.7 | 0.7 | 2.0696B | 3.78% | 2069.6M |
FQ4 2023 (Oct 2023) | 0.97 | 0.97 | 2.0929B | 3.91% | 2092.9M |
FQ3 2023 (Jul 2023) | 1.48 | 1.48 | 2.0282B | 3.29% | 2028.2M |
FQ4 Announce Date
07/31/2025 (Pre-Market)
Consensus EPS Estimates
0.97976
Consensus Revenue Estimates
2.105186714B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Oct 2027) | 1.27297 | -- | 1.24646 | 1.31087 | 5 |
FQ3 2027 (Jul 2027) | 1.19503 | -- | 1.17015 | 1.23061 | 3 |
FQ2 2027 (Apr 2027) | 1.10174 | -- | 1.0788 | 1.13454 | 5 |
FQ1 2027 (Jan 2027) | 1.06254 | -- | 1.01638 | 1.07855 | 5 |
FQ4 2026 (Oct 2026) | 1.18 | -- | 1.16401 | 1.19942 | 2 |
FQ3 2026 (Jul 2026) | 1.01 | -- | 0.99631 | 1.02662 | 2 |
FQ2 2026 (Apr 2026) | 0.98 | 31.63 | 0.96672 | 0.99613 | 2 |
FQ1 2026 (Jan 2026) | 0.89 | 21.35 | 0.89 | 0.89 | 2 |
FQ4 2025 (Oct 2025) | 1.06998 | 117.76 | 1.05548 | 1.08759 | 4 |
FQ3 2025 (Jul 2025) | 0.97976 | 92.4 | 0.94347 | 1.00138 | 2 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Oct 2027) | 2.38B | -- | 2.34B | 2.43B | 6 |
FQ3 2027 (Jul 2027) | 2.27B | -- | 2.23B | 2.32B | 4 |
FQ2 2027 (Apr 2027) | 2.16B | -- | 2.13B | 2.21B | 6 |
FQ1 2027 (Jan 2027) | 2.24B | -- | 2.17B | 2.27B | 6 |
FQ4 2026 (Oct 2026) | 2.24B | -- | 2.21B | 2.27B | 3 |
FQ3 2026 (Jul 2026) | 2.16B | -- | 2.14B | 2.19B | 3 |
FQ2 2026 (Apr 2026) | 2.14B | 1.32 | 2.12B | 2.17B | 3 |
FQ1 2026 (Jan 2026) | 2.17B | 2.31 | 2.17B | 2.17B | 3 |
FQ4 2025 (Oct 2025) | 2.14B | -1.75 | 2.12B | 2.17B | 3 |
FQ3 2025 (Jul 2025) | 2.11B | 0.52 | 2.05B | 2.14B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Apr 2025) | 0.67 | 0.67 | 100% | |
FQ1 2025 (Jan 2025) | 0.7 | 0.7 | 100% | |
FQ4 2024 (Oct 2024) | -0.19 | -0.19 | 100% | |
FQ3 2024 (Jul 2024) | 0.0745 | 0.0745 | 100% | |
FQ2 2024 (Apr 2024) | 0.69 | 0.69 | 100% | |
FQ1 2024 (Jan 2024) | 0.7 | 0.7 | 100% | |
FQ4 2023 (Oct 2023) | 0.97 | 0.97 | 100% | |
FQ3 2023 (Jul 2023) | 1.48 | 1.48 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Apr 2025) | $0B | $2.11B | $2111.7M | 100% |
FQ1 2025 (Jan 2025) | $0B | $2.11B | $2114.9M | 100% |
FQ4 2024 (Oct 2024) | $0B | $2.18B | $2177.3M | 100% |
FQ3 2024 (Jul 2024) | $0B | $2.09B | $2094.2M | 100% |
FQ2 2024 (Apr 2024) | $0B | $2.02B | $2018.2M | 100% |
FQ1 2024 (Jan 2024) | $0B | $2.07B | $2069.6M | 100% |
FQ4 2023 (Oct 2023) | $0B | $2.09B | $2092.9M | 100% |
FQ3 2023 (Jul 2023) | $0B | $2.03B | $2028.2M | 100% |